Statin Discontinuation in High-Risk Patients: A Systematic Review of the Evidence

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|33|3669-3689

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.33, 2011-11, pp. : 3669-3689

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs: A Systematic Review and Meta-Analysis

By Khalaf Mohamad M. Al  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 29-43

Adis International

Access to resources Recommend Favorite

Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study

By Chapman Richard H.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 299-308

Adis International

Access to resources Recommend Favorite

Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R.   Perry Caroline M.   Robinson Dean M.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

Renal Transplantation in High-Risk Patients

By Weimert Nicole A.  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1603-1627

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups: A Systematic Review

By John-Baptiste Ava   >   Leung Victoria   >   Krahn Murray  

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 1015-1034

Adis International

Access to resources Recommend Favorite